Alexandre Ponomarenko

The paper applies the NaaS methodology to model chemotherapy-induced peripheral neuropathy using human hiPSC neurons, showing drug-specific changes in neuronal activity.

The paper uses a brain-on-chip platform with human neurons to differentiate Alzheimer's disease and healthy CSF samples based on electrophysiological responses to Aβ peptides.